PWA
GILD icon

Providence Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Providence Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
15,197
-60
-0.4% -$7.91K 1.17% 26
2026
Q1 		$2.14M Buy
15,257
+294
+2% +$41.2K 1.36% 24
2025
Q4 		$1.76M Buy
14,963
+128
+0.9% +$15.6K 1.1% 29
2025
Q3 		$1.75M Buy
14,835
+95
+0.6% +$10.8K 1.1% 29
2025
Q2 		$1.62M Buy
14,740
+239
+2% +$25.4K 1.11% 32
2025
Q1 		$1.61M Buy
14,501
+34
+0.2% +$3.51K 1.22% 30
2024
Q4 		$1.32M Sell
14,467
-55
-0.4% -$4.95K 1% 33
2024
Q3 		$1.28M Buy
14,522
+425
+3% +$32.4K 0.94% 35
2024
Q2 		$981K Buy
14,097
+709
+5% +$47.3K 0.78% 42
2024
Q1 		$964K Sell
13,388
-8,674
-39% -$667K 0.82% 42
2023
Q4 		$4.28M Buy
22,062
+9,921
+82% +$772K 3.87% 4
2023
Q3 		$892K Buy
12,141
+141
+1% +$10.8K 1% 35
2023
Q2 		$927K Buy
12,000
+460
+4% +$36.7K 1.03% 32
2023
Q1 		$970K Sell
11,540
-1,190
-9% -$98.6K 0.72% 43
2022
Q4 		$1.09M Buy
12,730
+217
+2% +$17.2K 0.81% 41
2022
Q3 		$1.04M Sell
12,513
-10
-0.1% -$631 0.78% 42
2022
Q2 		$780K Buy
12,523
+1,270
+11% +$78.6K 0.56% 55
2022
Q1 		$671K Buy
11,253
+338
+3% +$21.6K 0.43% 65
2021
Q4 		$786K Buy
10,915
+1,405
+15% +$96.8K 0.49% 57
2021
Q3 		$651K Buy
+9,510
New +$668K 0.45% 64

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Providence Wealth Advisors's GILD Position: Q2 2026 in Review

Providence Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.39% in Q2 2026, selling an estimated $7.91K and leaving 15,197 shares worth $1.99M. The position accounts for 1.17% of the portfolio, ranked #26.

Providence Wealth Advisors first reported a position in GILD in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.28M in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Providence Wealth Advisors held 15,197 shares of Gilead Sciences worth $1.99M as of Q2 2026.
  • Providence Wealth Advisors sold 60 Gilead Sciences shares in Q2 2026, an estimated $7.91K.
  • Gilead Sciences made up 1.17% of Providence Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • Providence Wealth Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 20 quarters since.
  • Providence Wealth Advisors's Gilead Sciences position peaked at $4.28M in Q4 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Providence Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.